CLINICAL TRIALS PROFILE FOR ANASCORP
✉ Email this page to a colleague
All Clinical Trials for ANASCORP
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00624078 ↗ | Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation | Completed | University of Arizona | Phase 2/Phase 3 | 2005-05-01 | This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation. |
NCT00624078 ↗ | Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation | Completed | Instituto Bioclon S.A. de C.V. | Phase 2/Phase 3 | 2005-05-01 | This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ANASCORP
Condition Name
Clinical Trial Locations for ANASCORP
Trials by Country
Clinical Trial Progress for ANASCORP
Clinical Trial Phase
Clinical Trial Sponsors for ANASCORP
Sponsor Name